SCHEMBL18238754

SCHEMBL18238754

CC(C)c1ccc(C(=O)c2ccc(-c3cnc4[nH]cc(C=CC(N)=O)c4c3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SGK1 O00141 4/20 0.43
▸ MAP3K11 Q16584 4/20 0.42
▸ CAMKK2 Q96RR4 5/20 0.42
▸ AXL P30530 4/20 0.42
▸ AAK1 Q2M2I8 1/20 0.41
▸ MAP3K7 O43318 3/20 0.41
▸ TAB1 Q15750 3/20 0.41
▸ DYRK1A Q13627 3/20 0.40
▸ CLK1 P49759 2/20 0.40
▸ DYRK2 Q92630 2/20 0.40
▸ DYRK1B Q9Y463 2/20 0.40
▸ CDC7 O00311 1/20 0.39
▸ PLK4 O00444 1/20 0.39
▸ CHEK1 O14757 1/20 0.39
▸ AURKA O14965 1/20 0.39
▸ MAPK13 O15264 1/20 0.39
▸ PDPK1 O15530 1/20 0.39
▸ DYRK3 O43781 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ RPS6KA5 O75582 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16949144 1.00 SGK1 (0.43) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL16948923 0.92 MAP3K11 (0.42) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL18238067 0.92 MAP3K11 (0.42) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL18238666 0.92 SGK1 (0.40) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL16948906 0.92 SGK1 (0.40) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL16948892 0.89 AAK1 (0.42) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL18238621 0.89 AAK1 (0.42) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL16949003 0.89 AXL (0.38) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL18239059 0.89 AXL (0.38) SGK1MAP3K11CAMKK2AXLAAK1
SCHEMBL18250466 0.89 AAK1 (0.47) SGK1MAP3K11CAMKK2AXLAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499551-B2 Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases CONFLUENCE LIFE SCIENCES, INC. (US) 2016-11-22 — — US disclosed
Send feedback